Matinas BioPharma (MTNB) Reports In-Line Q1 EPS

Matinas BioPharma (NYSE: MTNB) reported Q1 EPS of ($0.03), in-line with the analyst estimate of ($0.03).

For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform